Aclarion, Inc. (ACON) Fair Value 2026

ACON · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.1 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (54/100)

Quick Summary — As of 2026-08-28, Aclarion, Inc. (ACON) trades at $2.40. QOC: 5.1/10. Value Trap Risk: 54/100 (WARN). 1/13 models active.

Key Facts

Ticker
ACON
Price
$2.40
Quality Score
5.1/10
Value Trap Risk
54/100
Models Active
1/13
Last Updated
Strength: Dynamic NAV suggests +206.8% upside with 52% confidence
Risk: Value Trap score of 54 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give ACON?

1 Intrinsic Value Models vs. Current Price ($2.40)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $7.36 +206.8%

All Models Active

All 1 models are displayed above.

What Is Aclarion, Inc. (ACON) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Aclarion, Inc.'s intrinsic value is estimated at a median fair value of $7.36. At a current market price of $2.40, 1 of 1 active valuation models identify upside potential, projecting a median implied return of +206.8%.

What Do the Models Say About ACON?

1 of 13 models are currently active for ACON. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does ACON Rank in Health Information Services?

Among 55 Health Information Services stocks, ACON ranks #40 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

Aclarion, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ACON a Value Trap?

CirclFi's Value Trap algorithm assigns ACON a score of 54/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Aclarion, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Aclarion, Inc. is rated at 5.1/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ACON valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ACON's 1 active models, average confidence is 52%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Aclarion, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

CTEVClaritev CorporationQOC 5.6BRGXBioRegenx, Inc.QOC 5.1AMWLAmerican Well CorporationQOC 5.8LGMKLogicMark, Inc.QOC 4.9EVHEvolent Health, Inc.QOC 5.8MGRXMangoceuticals, Inc.QOC 4.8ESSIEco Science Solutions, Inc.QOC 3.9WAYWaystar Holding Corp.QOC 7.7TEMTempus AI, Inc.QOC 6.4DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: CTEV · BRGX · AMWL · LGMK · EVH · MGRX · ESSI · WAY · TEM · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to ACON?

7 companies across all industries closest to ACON’s Quality of Company score of 5.1/10.

OLMAOlema Pharmaceuticals, Inc.QOC 5.1AEROGrupo Aeromexico, S.A.B. de C.VQOC 5.1ARAIArrive AI Inc.QOC 5.1MACIMelar Acquisition Corp. IQOC 5.1IMVTImmunovant, Inc.QOC 5.1DYNDyne Therapeutics, Inc.QOC 5.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: OLMA · AERO · ARAI · MACI · IMVT · DYN · NVDA

Where Does ACON Sit in CirclFi's Health Information Services Rankings?

ACON is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Aclarion, Inc.’s Valuation?

What is Aclarion, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Aclarion, Inc. (ACON). The Quality of Company score is 5.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ACON overvalued or undervalued right now?

At $2.40, 1 of 1 active models suggest ACON may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Aclarion, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 5.1 mean for ACON?

Aclarion, Inc.'s QOC of 5.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ACON?

CirclFi analyzes ACON with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is ACON a value trap in 2026?

Aclarion, Inc.'s Value Trap score is 54/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Aclarion, Inc. (ACON) a Quality of Company score of 5.1/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/ACON/ · Methodology
Primary sources for this ACON valuation
  • Financial statements: Aclarion, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001635077) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ACON as of ; valuations recomputed .